A participant in the company’s late-stage coronavirus vaccine trial reportedly developed severe neurological symptoms. Now experts must assess whether the vaccine was responsible.
— NYT: Katherine J. Wu
Categories
Inquiry begins into AstraZeneca’s Coronavirus vaccine trial
